Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
International Journal of Chronic Obstructive Pulmonary Disease
Volume 16, 2021 - Issue
Original Research
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
Soham Shukla1 Value Evidence and Outcomes, GSK, Collegeville, PA, USA
https://orcid.org/0000-0002-4139-0856View further author information
https://orcid.org/0000-0002-4139-0856View further author information, , Alan Martin3 Value Evidence and Outcomes, GSK, Brentford, Middlesex, UKhttps://orcid.org/0000-0002-3673-3383View further author information
https://orcid.org/0000-0002-3673-3383View further author information, , Robyn Kendall5 Global Health Economics, and Outcomes Research and Epidemiology, ICON, Vancouver, BC, Canadahttps://orcid.org/0000-0001-6331-5497View further author information
https://orcid.org/0000-0001-6331-5497View further author information, , Isabelle Boucot3 Value Evidence and Outcomes, GSK, Brentford, Middlesex, UKhttps://orcid.org/0000-0003-0410-4969View further author information
https://orcid.org/0000-0003-0410-4969View further author information, , Leif Bjermer8 Respiratory Medicine and Allergology, Lund University, Lund, Swedenhttps://orcid.org/0000-0002-3441-8099View further author information
https://orcid.org/0000-0002-3441-8099View further author information, Paul W Jones3 Value Evidence and Outcomes, GSK, Brentford, Middlesex, UKhttps://orcid.org/0000-0001-6087-9182View further author information
https://orcid.org/0000-0001-6087-9182View further author information, Edward Kerwin9 Altitude Clinical Consulting and Clinical Research Institute of Southern Oregon, Medford, OR, USAhttps://orcid.org/0000-0002-1697-9036View further author information
https://orcid.org/0000-0002-1697-9036View further author information, , François Maltais10 Centre de Pneumologie, Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, QC, Canadahttps://orcid.org/0000-0002-6809-4651View further author information
https://orcid.org/0000-0002-6809-4651View further author information, David A Lipson11 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;12 Respiratory Clinical Sciences, GSK, Collegeville, PA, USAhttps://orcid.org/0000-0001-6732-4593View further author information
https://orcid.org/0000-0001-6732-4593View further author information & Afisi S Ismaila1 Value Evidence and Outcomes, GSK, Collegeville, PA, USA;13 Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-2876-8308View further author information
https://orcid.org/0000-0002-2876-8308View further author information show all